RAFAEL HOLDINGS, INC. Accounts and Other Receivables, Net, Current
RAFAEL HOLDINGS, INC. (RFL) had Accounts and Other Receivables, Net, Current of $231.00 thousand as of 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2023-12-14
- 2023-10-31: Accounts and Other Receivables, Net, Current $231.00K.
- 2023-07-31: Accounts and Other Receivables, Net, Current $213.00K; Accounts and Other Receivables, Net, Current as first filed $387.00K.
- 2023-04-30: Accounts and Other Receivables, Net, Current $352.00K.
- 2023-01-31: Accounts and Other Receivables, Net, Current $314.00K.
| Period end | Accounts and Other Receivables, Net, Current | Accounts and Other Receivables, Net, Current as first filed |
|---|---|---|
| 2023-10-31 | $231.00K 10-Q · filed 2023-12-14 | |
| 2023-07-31 | $213.00K 10-Q · filed 2023-12-14 | $387.00K 10-K · filed 2023-10-30 |
| 2023-04-30 | $352.00K 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $314.00K 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $171.00K 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $140.00K 10-K · filed 2023-10-30 | |
| 2022-04-30 | $258.00K 10-Q · filed 2022-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |